May-Zhang, Linda S.
Chen, Zhongyi
Dosoky, Noura S. http://orcid.org/0000-0002-4434-9146
Yancey, Patricia G.
Boyd, Kelli L.
Hasty, Alyssa H.
Linton, MacRae F.
Davies, Sean S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (AT07380, AT07380, AT07380, AT07830)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL116263, HL116263, HL116263)
Center for Strategic Scientific Initiatives, National Cancer Institute (CA068485)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK059637)
Article History
Received: 31 May 2018
Accepted: 13 November 2018
First Online: 23 January 2019
Competing Interests
: S.S.D. and Z.C. have a patent pending for the use of engineered bacteria expressing NAPE or NAE for treating obesity. S.S.D. receives funding from National Institutes of Health for studies using engineered bacteria.